Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|10|1|6-12

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.10, Iss.1, 2017-01, pp. : 6-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5746-5752

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer Therapy: Targeting the Mevalonate Pathway

By  

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 15-37

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Mevalonate Pathway for Improved Anticancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 626-638

Bentham Science Publishers

Access to resources Recommend Favorite

The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 247-256

Bentham Science Publishers

Access to resources Recommend Favorite

New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 327-340

Bentham Science Publishers

Access to resources Recommend Favorite